Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 9

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 3
Chunk 9
---
 to lose trust in each other, give rise to conflicts between
employees, and failure to meet their responsibilities. Consequently, EUDA’s business may lose revenue and miss out on potential
opportunities. Moreover, in other scenarios, it could result in lawsuits, defamation, or similar negative outcomes. Such cases may require
sanctions from the senior management of EUDA leading up to and including termination of employment.

EUDA
has incurred, and may incur, significantly increased costs and has continued to devote substantial management time as a result of operating
as a public company.

As
a public company, EUDA has incurred significant costs related to legal, accounting, listing, hiring of external consultants and advisors,
and other expenses. EUDA expects that management and other personnel will need to divert attention from operational and other business
matters to devote substantial time to these public company requirements. EUDA may also need to hire additional accounting and financial
staff with appropriate public company experience and technical accounting knowledge and establish an internal audit function.

Operating
as a public company has also made it more expensive to obtain director and officer liability insurance and the Company may be required
to accept reduced coverage or incur substantially higher costs to obtain coverage. This could also make it more difficult for EUDA to
attract and retain qualified people to serve on its board of directors, its board committees or as executive officers.

As
an emerging growth company, EUDA is subject to reduced reporting requirements applicable to emerging growth companies.

EUDA
is an emerging growth company, as defined in the JOBS Act. For as long as EUDA continues to be an emerging growth company, it may take
advantage of exemptions from various reporting requirements that are applicable to other public companies that are not “emerging
growth companies,” including exemption from compliance with the auditor attestation requirements of Section 404, reduced disclosure
obligations regarding executive compensation and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved. The Company will remain an emerging growth
company until the earlier of: (1) December 31, 2027 (the last day of the fiscal year following the fifth anniversary of the consummation
of the Company’s initial public offering), (2) the last day of the fiscal year in which we have total annual gross revenue of at
least $1.235 billion, (3) the last day of the fiscal year in which we are deemed to be a large accelerated fil